Search by Drug Name or NDC
NDC 54838-0117-80 Siltussin SA 100 mg/5mL Details
Siltussin SA 100 mg/5mL
Siltussin SA is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Lannett Company, Inc.. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 54838-0117-80Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 54838-0117 |
|---|---|
| Product ID | 54838-117_0c91f982-f8fd-450c-86eb-3f49f4ef11d5 |
| Associated GPIs | 43200010001210 |
| GCN Sequence Number | 022210 |
| GCN Sequence Number Description | guaifenesin LIQUID 100 MG/5ML ORAL |
| HIC3 | B3J |
| HIC3 Description | EXPECTORANTS |
| GCN | 02512 |
| HICL Sequence Number | 000271 |
| HICL Sequence Number Description | GUAIFENESIN |
| Brand/Generic | Generic |
| Proprietary Name | Siltussin SA |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/5mL |
| Substance Name | GUAIFENESIN |
| Labeler Name | Lannett Company, Inc. |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | n/a |
Package
Package Images
NDC 54838-0117-80 (54838011780)
| NDC Package Code | 54838-117-80 |
|---|---|
| Billing NDC | 54838011780 |
| Package | 473 mL in 1 BOTTLE, PLASTIC (54838-117-80) |
| Marketing Start Date | 1998-10-05 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.01272 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | SILTUSSIN SA 100 MG/5 ML SYR |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL 42d3ce76-5a3d-4936-bc75-2f703dd3b423 Details
SPL UNCLASSIFIED SECTION
Warnings
Ask a doctor before use if you have
- cough that occurs with too much phlegm (mucus)
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
Directions
- do not take more than 6 doses in any 24-hour period
- repeat dose every 4 hours
| adults and children 12 years and over | 2-4 teaspoonfuls (TSP) |
| children under 12 years | DO NOT USE |
Other information
Store at room temperature 20°-25°C (68°-77°F). Do not accept if imprinted tamper evident safety seal around cap is broken or missing.
Inactive ingredients
SPL UNCLASSIFIED SECTION
INGREDIENTS AND APPEARANCE
| SILTUSSIN SA
guaifenesin liquid |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| Labeler - Lannett Company, Inc. (002277481) |
Revised: 6/2021
Document Id: 0c91f982-f8fd-450c-86eb-3f49f4ef11d5
Set id: 42d3ce76-5a3d-4936-bc75-2f703dd3b423
Version: 18
Effective Time: 20210611